Wednesday, May 16, 2018

Imprimis offshoot raises $20M to develop dry-eye meds

FierceBiotech-22 hours ago
RELATED: Imprimis spins out dry eye disease drugs to create biotech. Imprimis has a history of identifying compounded drugs it believes can win their own FDA ...
Post a Comment